Carmel Capital Partners’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-259	Closed	-$3.63K	–	665
2023 Q3	$3.63K	Buy	259 +59	+30%	+$827	﹤0.01%	582
2023 Q2	$2.07K	Buy	+200	New	+$2.07K	﹤0.01%	362